KONSYL ORANGE SF OTC
Generic Name and Formulations:
Psyllium hydrophilic mucilloid 3.5g; per packet or rounded teaspoon; sugar-free pwd; contains phenylalanine.
Indications for KONSYL ORANGE SF:
Adults and Children:
Mix in 8oz liq, then drink 8oz more liq. <6yrs: not recommended. 6–12yrs: ½ adult dose. ≥12yrs: 1 packet or rounded teaspoonful (1 rounded tablespoonful for Konsyl Orange) 1–3 times daily.
Signs/symptoms of appendicitis. Intestinal obstruction. Fecal impaction.
Rectal bleeding. Diabetes (sugar-containing forms).
Tablets block tetracycline absorption (give at least 1hr before or 2hrs after tetracycline).
Esophageal, gastric, enteral, rectal obstruction.
Original—10.6oz, 15.9oz; Original packets—30; D—11.5oz, 17.5oz; Orange—19oz; Sugar-Free—10.6oz, 15.9oz; Sugar-Free packets—30; Sugar-Free Orange—15oz; Easy Mix—8.8oz (w. scoop); Tabs—90; Caps—100
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies